Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Cytokinetics Inc. buy B. Riley

Start price
€44.60
04.06.24 / 50%
Target price
€84.53
04.06.25
Performance (%)
-35.43%
End price
€28.80
05.06.25
Summary
This prediction ended on 05.06.25 with a price of €28.80. Massive losses of -35.43% were the result for the BUY prediction by B__Riley. B__Riley has a follow-up prediction for Cytokinetics Inc. where he still thinks Cytokinetics Inc. is a Buy. B__Riley has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Cytokinetics Inc. -5.983% -5.983% 14.108%
iShares Core DAX® 0.697% -0.987% 18.440%
iShares Nasdaq 100 1.661% -1.837% 9.500%
iShares Nikkei 225® 0.922% -7.458% 10.635%
iShares S&P 500 0.430% -0.851% 3.017%

Comments by B__Riley for this prediction

In the thread Discuss Cytokinetics Inc.
Prediction Buy
Perf. (%) -35.43%
Target price 84.530
Change
Ends at 04.06.25

Cytokinetics, Incorporated (NASDAQ: CYTK) had its price target lowered by analysts at B. Riley from $122.00 to $92.00. They now have a "buy" rating on the stock.
Ratings data for CYTK provided by MarketBeat

In the thread Trading Cytokinetics Inc.
Prediction Buy
Perf. (%) -35.43%
Target price 84.530
Change
Ends at 04.06.25

Die von B__Riley gewählte maximale Laufzeit wurde überschritten

Current prediction by B__Riley for Cytokinetics Inc.

buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€41.00
22.09.25
€68.18
22.09.26
36.59%
18:40

Stopped prediction by B__Riley for Cytokinetics Inc.

buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€53.50
10.11.25
€77.87
10.11.26
4.67%
18:40

buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€33.40
07.11.23
€61.81
07.11.24
61.68%
08.11.24